(Q42937799)

11 November 2017

title

Effect of eslicarbazepine acetate and oxcarbazepine on cognition and psychomotor function in healthy volunteers (English)

1 reference

11 November 2017

7

1 reference

11 November 2017

Patrício Soares-da-Silva

8

1 reference

11 November 2017

Luis Almeida

2

0 references

author name string

Denise Milovan

1

1 reference

11 November 2017

Myroslava K Romach

3

1 reference

11 November 2017

Teresa Nunes

4

1 reference

11 November 2017

José Francisco Rocha

5

1 reference

11 November 2017

Marta Sokowloska

6

1 reference

11 November 2017

publication date

18 June 2010

1 reference

11 November 2017

1 reference

11 November 2017

volume

18

1 reference

11 November 2017

issue

4

1 reference

11 November 2017

page(s)

366-373

1 reference

Mechanisms of action of carbamazepine and its derivatives, oxcarbazepine, BIA 2-093, and BIA 2-024.

11 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.04.022

Anticonvulsant and sodium channel-blocking properties of novel 10,11-dihydro-5H-dibenz[b,f]azepine-5-carboxamide derivatives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.04.022

Efficacy and safety of eslicarbazepine acetate as adjunctive treatment in adults with refractory partial-onset seizures: a randomized, double-blind, placebo-controlled, parallel-group phase III study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.04.022

Efficacy and safety of 800 and 1200 mg eslicarbazepine acetate as adjunctive treatment in adults with refractory partial-onset seizures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.04.022

7 January 2021

Oxcarbazepine: a review

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.04.022

Oxcarbazepine for Treatment of Partial Epilepsy: A Review and Recommendations for Clinical Use

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.04.022

Oxcarbazepine: an update of its efficacy in the management of epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.04.022

Cognitive and behavioral effects of lamotrigine and topiramate in healthy volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.04.022

Pharmacodynamics of milnacipran in young and elderly volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.04.022

Pharmacologic effects and abuse liability of bretazenil, diazepam, and alprazolam in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.04.022

High-Speed Scanning in Human Memory

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.04.022

The psychomotor effects of carbamazepine in epileptic patients and healthy volunteers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.04.022

Single-dose and steady-state pharmacokinetics of eslicarbazepine acetate (BIA 2-093) in healthy elderly and young subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.04.022

Metabolism of two new antiepileptic drugs and their principal metabolites S(+)- and R(-)-10,11-dihydro-10-hydroxy carbamazepine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.04.022

Enantioselective pharmacokinetics of 10-hydroxycarbazepine after oral administration of oxcarbazepine to healthy Chinese subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.04.022

Pharmacokinetics of eslicarbazepine acetate in patients with moderate hepatic impairment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.04.022

Neurotoxicity induced by antiepileptic drugs in cultured hippocampal neurons: a comparative study between carbamazepine, oxcarbazepine, and two new putative antiepileptic drugs, BIA 2-024 and BIA 2-093.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.04.022

Oxcarbazepine, not its active metabolite, potentiates GABAA activation and aggravates absence seizures.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.04.022

10.1016/J.YEBEH.2010.04.022

7 January 2021

Identifiers

DOI

1 reference

11 November 2017

1 reference